- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.12.25 | EC approves Roche's Gazyva to treat active lupus nephritis | ||
| 09.12.25 | Inductive Bio gains $21m ARPA-H funds for drug prediction models | ||
| 08.12.25 | Medical bodies sound alarm over US hepatitis B vaccine vote | ||
| 08.12.25 | Viatris signs agreements with Biocon on $815m stake sale | ||
| 08.12.25 | Agilent and Monash University Malaysia to set up biodiscovery hub | ||
| 05.12.25 | CDC panel votes to revoke newborn hepatitis B vaccine recommendation | ||
| 05.12.25 | Crescent and Kelun-Biotech swap cancer asset rights in double deal | ||
| 05.12.25 | Denali makes $275m funding agreement with Royalty Pharma | ||
| 05.12.25 | Takeda and Innovent fulfil close conditions for ADC and IO therapies | ||
| 04.12.25 | Former FDA commissioners unite to condemn US vaccine proposals | ||
| 04.12.25 | FDA appoints Tracy Beth Høeg as fifth CDER head this year | ||
| 04.12.25 | Formosa and Rxilient sign licensing agreement for APP13007 | ||
| 04.12.25 | FDA approves Eli Lilly's Jaypirca in relapsed or refractory CLL/SLL | ||
| 03.12.25 | Richard Padzur to leave FDA following recent CDER leadership shift | ||
| 03.12.25 | AGC Biologics to expand cell line development with ATUM partnership | ||
| 03.12.25 | Citizen Health and UCB collaborate for epilepsy drug development | ||
| 02.12.25 | FDA steps back from preclinical primate testing amid wider regulatory shift | ||
| 02.12.25 | WHO backs use of GLP-1RAs for weight loss despite shortage warning | ||
| 02.12.25 | House passes bill that reauthorises the FDA's paediatric priority voucher pathway | ||
| 02.12.25 | Solid Biosciences' SGT-212 gains FDA rare paediatric disease status | ||
| 02.12.25 | Lotus submits NDA for VIZZ in South Korea to treat presbyopia | ||
| 01.12.25 | UK and US strike "landmark" zero-tariff pharma deal | ||
| 01.12.25 | Regeneron and Tessera join forces to forge in vivo AATD gene therapy | ||
| 01.12.25 | "Sharp" funding cuts disrupt PrEP access to millions of HIV patients | ||
| 01.12.25 | Eisai seeks PMDA approval for subcutaneous Leqembi in Japan |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.